The China Youth Science and Technology Award is a biennial award for young sci-tech workers across the country with the purpose of commending the distinguished accomplishments achieved by Chinese scientists and promoting the field of science in the nation.
The awardees were considered "dare to venture, dare to try, dare to be the first in the world, and have made outstanding contributions and outstanding influences in scientific and technological innovation, management innovation, institutional innovation, and cultural innovation".
From September 27th to September 28th, a team of the College of Engineering (COE) led by Prof. Huiling Duan, Dean of the College of Engineering, paid a visit to Nanchang City in Jiangxi Province, as an effort to jointly found Peking University Nanchang Innovation Research Institute.
The findings in this study deepen our understanding of the unique fracture mechanics of composites containing sophisticated micro-architectures and help the design of novel bio-inspired materials.
Recently, Prof. Qing Zhang’s research group from the College of Engineering, Peking University, made new progresses on the exciton polariton (EP) and continuous-wave (CW) pumped green halide perovskite semiconductor microlaser.
More than 300 students at levels varying from middle school to college participated in the event, which was presided over by Professor Yue Yang, deputy director of LTCS.
On September 1, Peking University (PKU) campus embraced thousands of new entrants of the academic year 2020-2021 from nationwide on their first day of university.
The meeting for development strategy was recently held in the College of Engineering, where the college administration, teachers and staff sat together to discuss the development direction for the coming academic year.
All COE leaders and teacher representatives, along with parents and families of some graduates shared this joyous moment with the graduates.
On June 24, 2020, the research team led by Prof. Jianzhong Xi from Peking University published an article named ‘Patient-Derived Tumor-Like Cell Clusters for Drug Testing in Cancer Therapy’ in Science Translational Medicine.